As people with prostates (PwP) get older, they are more likely to have prostatic conditions such as BPH, prostatitis, and prostate cancer. Screening for prostate cancer can be considered using the prostate-specific antigen (PSA) test alone, or in conjunction with a digital rectal exam (in which the clinician uses a finger through the rectum to feel for prostate growths)—guidelines vary. Per the Canadian Urological Association in 2022, the recommended age to consider starting for prostate cancer screening is around 50 years of age for those who are at average risk. However, it is recommended that those at higher risk, including African, Caribbean, and Black (ACB) men, consider screening for prostate cancer earlier at age 45.
Mpox – Sexual Networks, HIV and Activism (webinar recording)
Topics and speakers:
- MPX NYC: A community-led study on queer sex in New York Cit Dr. Keletso Makofane, Harvard University, FXB Health & Human Rights Fellow
- Mpox and HIV Dr. Chloe Orkin, Professor of HIV Medicine, Queen Mary University of London